Comment on: Biscetti et al. (2010) High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes;59:1496-1505.
作者信息
Germani Antonia, Capogrossi Maurizio C
出版信息
Diabetes. 2010 Jul;59(7):e7; author reply e8. doi: 10.2337/db10-0445.
PMID:20587797
Abstract
摘要
相似文献
1
Comment on: Biscetti et al. (2010) High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes;59:1496-1505.评论：比塞蒂等人（2010年）。高迁移率族蛋白盒1通过血管内皮生长因子依赖机制促进糖尿病小鼠外周缺血后的血管生成。《糖尿病》；59:1496 - 1505。
Diabetes. 2010 Jul;59(7):e7; author reply e8. doi: 10.2337/db10-0445.
2
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.高迁移率族蛋白 B1 通过血管内皮生长因子依赖机制促进糖尿病小鼠周围缺血后的血管生成。
Diabetes. 2010 Jun;59(6):1496-505. doi: 10.2337/db09-1507. Epub 2010 Mar 3.
3
In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.在2型糖尿病小鼠中，一种血管内皮生长因子（VEGF）激活转录因子可调节VEGF信号传导，并在后肢缺血后诱导治疗性血管生成。
Diabetes. 2007 Mar;56(3):656-65. doi: 10.2337/db06-0999.
4
Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.2型糖尿病患者后肢缺血后血管生成受损：血管内皮生长因子受体1和可溶性血管内皮生长因子受体1的差异调节
Circ Res. 2007 Oct 26;101(9):948-56. doi: 10.1161/CIRCRESAHA.107.160630. Epub 2007 Sep 6.
5
Histidine-rich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis in matrigel plug assay.组氨酸丰富糖蛋白与肝素结合抑制高迁移率族蛋白 B1 诱导的基质胶塞法血管生成。
Eur J Pharmacol. 2009 Nov 25;623(1-3):89-95. doi: 10.1016/j.ejphar.2009.09.010. Epub 2009 Sep 26.
6
Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration.高迁移率族蛋白1在骨骼肌再生中的多种作用
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2377-83. doi: 10.1161/ATVBAHA.107.153429. Epub 2007 Sep 13.
7
Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.血管内皮细胞对趋化因子/ CX3CR1的激活通过血管内皮生长因子-A/激酶插入域受体诱导血管生成，并逆转后肢缺血。
Cardiovasc Res. 2008 May 1;78(2):333-40. doi: 10.1093/cvr/cvm067. Epub 2007 Nov 11.
8
Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.抑制神经信号蛋白作为一种新的治疗性血管生成策略。
Circ Res. 2010 Feb 5;106(2):391-8. doi: 10.1161/CIRCRESAHA.109.210815. Epub 2009 Nov 25.
9
A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.磷酸二酯酶-5 抑制剂伐地那非通过蛋白激酶 G 依赖性缺氧诱导因子-1/血管内皮生长因子通路促进血管生成。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1315-24. doi: 10.1161/ATVBAHA.109.201327. Epub 2010 Apr 22.
10
Vascular endothelial growth factor-B promotes in vivo angiogenesis.血管内皮生长因子-B促进体内血管生成。
Circ Res. 2003 Jul 25;93(2):114-23. doi: 10.1161/01.RES.0000081594.21764.44. Epub 2003 Jun 12.
Zotero 插件